Mesa Laboratories (MLAB)
(Delayed Data from NSDQ)
$128.57 USD
+0.14 (0.11%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $128.98 +0.41 (0.32%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth D Momentum B VGM
Mesa Labs (MLAB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$130.00 | $150.00 | $120.00 | 1.22% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Mesa Labs comes to $130.00. The forecasts range from a low of $120.00 to a high of $150.00. The average price target represents an increase of 1.22% from the last closing price of $128.43.
Analyst Price Targets (3 )
Broker Rating
Mesa Labs currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.67 a month ago based on three recommendations.
Of the four recommendations deriving the current ABR, two are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 66.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 0 | 0 | 0 |
ABR | 2.50 | 2.50 | 1.67 | 1.67 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Strong Sell |
8/12/2024 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
8/6/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.50 |
ABR (Last week) | 2.50 |
# of Recs in ABR | 4 |
Average Target Price | $130.00 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 2.48 |
MLAB FAQs
Mesa Laboratories, Inc. (MLAB) currently has an average brokerage recommendation (ABR) of 2.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Mesa Laboratories, Inc. (MLAB) is $130.00. The current on short-term price targets is based on 1 reports.
The forecasts for Mesa Laboratories, Inc. (MLAB) range from a low of $120 to a high of $150. The average price target represents a increase of $1.11 from the last closing price of $128.57.
The current UPSIDE for Mesa Laboratories, Inc. (MLAB) is 1.11%
Based on short-term price targets offered by three analysts, the average price target for Mesa Labs comes to $130.00. The forecasts range from a low of $120.00 to a high of $150.00. The average price target represents an increase of 1.22% from the last closing price of $128.43.